Retirement Stock Portfolio: 5 Low Risk Investments

2. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 88

Dividend Yield as of 12/10: 3.05%

Beta Value: 0.57

Johnson & Johnson (NYSE:JNJ), established in 1886, is a well-known American multinational corporation recognized for its pioneering work in medical devices, pharmaceuticals, and consumer packaged goods. Notably, the pharmaceutical arm of the company has an impressive streak of continuous dividend growth, spanning 62 years. Presently, Johnson & Johnson (NYSE:JNJ) distributes a quarterly dividend of $1.19 per share, equating to a dividend yield of 3.05% as of October 12.

During Q2 2023, the number of hedge funds monitored by Insider Monkey that held positions in Johnson & Johnson (NYSE:JNJ) rose to 88, up from 86 in the previous quarter. The combined stakes held by these hedge funds exceed a total value of $4.1 billion. The primary hedge fund investor in Johnson & Johnson (NYSE:JNJ) is Ray Dalio’s Bridgewater Associates, possessing a significant stake valued at approximately $526.58 million.